No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- PMID: 32240719
- PMCID: PMC7195369
- DOI: 10.1016/j.medmal.2020.03.006
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
References
-
- Chen J., Liu D., Lui L., et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 COVID-19) J Zhejiang Univ Sci. 2020;03:03-.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources